LEPU BIO 02157Hong Kong Stock Exchange

3.8200.65%( -0.025 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
LEPU BIO (02157) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2022-02-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100004SM4
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.10B53/112
Net Profit (Last FY)306.49M35/125
ROE (Last FY)18.85%12/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Pu Zhongjie Executive Director
Sui Ziye Executive Director
Pu Jue Non-Executive Director
Qin Yiran Non-Executive Director
Zhou Demin Independent Non-Executive Director
Yang Haifeng Independent Non-Executive Director
Fengmao Hua Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-06-27.

About this page

This page shows LEPU BIO (02157) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.